Averbis is a German software company that develops natural language processing (NLP) and machine learning solutions for the healthcare and life sciences sectors. The company focuses on extracting structured information from unstructured medical texts, such as clinical notes, radiology reports, and discharge summaries, to support clinical documentation, research, and decision-making. Averbis was founded in 2008 as a spin-off from the University of Freiburg and is headquartered in Freiburg im Breisgau, Germany.
The company's core technology leverages Artificial intelligence and Machine learning to build domain-specific language models and text-mining pipelines. Averbis's products are designed to integrate with existing hospital information systems and electronic health records, enabling healthcare providers to unlock insights from free-text data. The company serves a range of clients, including university hospitals, pharmaceutical companies, and medical research institutions across Europe.
History and Founding
Averbis was established in 2008 by a team of researchers from the University of Freiburg's Department of Medical Informatics. The founders, including Dr. Udo Hahn, a professor of computational linguistics, aimed to commercialize academic research on text mining for biomedical applications. The company initially focused on developing tools for named entity recognition and relation extraction in medical documents, with early projects funded by German federal research grants.
In 2012, Averbis launched its flagship product, Averbis Health Discovery, a platform for analyzing clinical data using NLP. The platform was adopted by several German university hospitals, including the University Medical Center Freiburg, for applications such as adverse event detection and clinical trial recruitment. By 2015, the company expanded its offerings to include a cloud-based version, allowing smaller clinics to access its tools without on-premise infrastructure.
Products and Technology
Averbis's primary product, Averbis Health Discovery, combines rule-based and Deep learning approaches to process medical text. The platform includes modules for entity recognition, document classification, and information extraction, all tailored to medical terminology and ontologies like SNOMED CT and ICD-10. The system supports multiple languages, including German, English, and French, and can be customized for specific clinical domains.
The company also offers Averbis Terminology Server, a tool for managing and mapping medical vocabularies, and Averbis Clinical Data Warehouse, which provides a unified interface for querying structured and unstructured patient data. In recent years, Averbis has integrated Large language model capabilities into its pipeline, using transformer-based architectures to improve accuracy on complex tasks like temporal relation extraction and negation detection.
Averbis emphasizes interoperability and compliance with healthcare regulations, including the European Union's General Data Protection Regulation (GDPR). Its software is deployed on-premises or in private clouds to ensure data privacy, a key requirement for medical institutions handling sensitive patient information.
Applications and Use Cases
The primary applications of Averbis's technology include clinical documentation improvement, where the software automatically codes diagnoses and procedures from physician notes, reducing manual effort and errors. The company's tools are also used for pharmacovigilance, enabling pharmaceutical companies to mine adverse drug reaction reports from clinical trial data and social media. In academic research, Averbis supports cohort identification by scanning electronic health records to find patients meeting specific inclusion criteria.
Another significant use case is in radiology, where Averbis extracts findings from imaging reports to populate structured databases for quality assurance and research. The company has collaborated with institutions like the University Hospital of Zurich to develop NLP models for German-language radiology texts, demonstrating the adaptability of its technology to non-English languages.
Market Position and Partnerships
Averbis operates in the competitive field of medical NLP, which includes larger players like IBM Watson Health and specialized startups such as Linguamatics (now part of IQVIA). The company differentiates itself through its focus on European healthcare systems and its support for multiple languages, including German, which is often underserved by US-based competitors. Averbis has established partnerships with technology providers like Amazon Web Services and Microsoft Azure to offer its solutions on cloud platforms, while maintaining on-premise options for clients with strict data governance requirements.
In 2020, Averbis received a strategic investment from the German healthcare group CompuGroup Medical, which integrated Averbis's NLP tools into its own electronic health record products. This partnership expanded Averbis's reach to thousands of physicians in Germany and other European countries. As of 2024, the company employs approximately 40 people and continues to grow its customer base in the DACH region and beyond.
Future Directions
Averbis is actively exploring the use of Generative AI and Transformer (architecture) models to enhance its text-mining capabilities. The company is researching methods to reduce the need for annotated training data, using techniques like Curriculum Learning and Data Augmentation to improve model performance with limited resources. Averbis also aims to expand into new therapeutic areas, such as oncology and rare diseases, where structured data extraction can accelerate clinical research.
The company is part of several European research consortia focused on health data sharing and interoperability, including the EU-funded projects that aim to create a European Health Data Space. Averbis's long-term vision is to become a standard infrastructure layer for medical text processing, enabling seamless data exchange and analysis across healthcare systems.
See Also
References
- Averbis GmbH company website, 'About Us'.
- University of Freiburg, Department of Medical Informatics, 'Spin-off Companies'.
- CompuGroup Medical press release, 'Strategic Investment in Averbis', 2020.
- European Commission, 'European Health Data Space' project documentation.